Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients

Roca-Rodríguez,M. M.; García-Almeida,J.  M.; Lupiañez-Pérez,Y.; Rico,J.  M.; Toledo,M.; Alcaide-Torres,J.; Cardona,F.; Medina,J.  A.; Tinahones,F.  J.

doi:10.3892/or.2013.2806

Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients

Authors:
- M. M. Roca-Rodríguez
- J. M. García-Almeida
- Y. Lupiañez-Pérez
- J. M. Rico
- M. Toledo
- J. Alcaide-Torres
- F. Cardona
- J. A. Medina
- F. J. Tinahones
View Affiliations

Affiliations: Virgen de la Victoria Hospital Investigation Unit (IMABIS), Malaga, Spain, Department of Endocrinology and Nutrition, Virgen de la Victoria Hospital, Malaga, Spain, Department of Clinical and Radiotherapeutic Oncology, Virgen de la Victoria Hospital, Malaga, Spain
Published online on: October 23, 2013 https://doi.org/10.3892/or.2013.2806
Pages: 405-414

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malnutrition affects 40-50% of patients with ear, nose and throat (ENT) cancer. The aim of this study was to assess changes induced by a specific nutritional supplement enriched with n-3 polyunsaturated fatty acids, fiber and greater amounts of proteins and electrolytes, as compared with a standard nutritional supplement, on markers of inflammation, oxidative stress and metabolic status of ENT cancer patients undergoing radiotherapy (RT). Fourteen days after starting RT, 26 patients were randomly allocated to one of two groups, 13 supplemented with Prosure®, an oncologic formula enriched with n-3 polyunsaturated fatty acids, fiber and greater amounts of proteins and electrolytes (specific supplement), and 13 supplemented with Standard-Isosource® (standard supplement). Patients were evaluated before RT, and 14, 28 and 90 days after starting RT. The results showed that there were no significant differences between the groups, but greater changes were observed in the standard supplement group, such as a decline in body mass index (BMI), reductions in hematocrit, erythrocyte, eosinophil and albumin levels, and a rise in creatinine and urea levels. We concluded that metabolic, inflammatory and oxidative stress parameters were altered during RT, and began to normalize at the end of the study. Patients supplemented with Prosure showed an earlier normalization of these parameters, with more favorable changes in oxidative stress markers and a more balanced evolution, although the difference was not significant.

View Figures

View References

1	Koom WS, Ahn SD, Song SY, Lee CG, Moon SH, Chie EK, Jang HS, Oh YT, Lee HS and Keum KC: Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J. 30:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
2	Righini CA, Timi N, Junet P, Bertolo A, Reyt E and Atallah I: Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 130:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
3	Martín-Villares C, San Román-Carbajo J, Fernández-Pello ME, Tapia Risueño M and Domínguez Calvo J: Nutritional status in head and neck cancer patients: the impact on the prognosis. Nutr Hosp. 18:91–94. 2003.(In Spanish).
4	Borek C: Antioxidants and radiation therapy. J Nutr. 134:3207S–3209S. 2004.PubMed/NCBI
5	Michalowski AS: On radiation damage to normal tissues and its treatment. II Anti-inflammatory drugs. Acta Oncol. 33:139–157. 1994. View Article : Google Scholar : PubMed/NCBI
6	Peters LJ: Radiation therapy tolerance limits. For one or for all? - Janeway Lecture. Cancer. 77:2379–2385. 1996. View Article : Google Scholar : PubMed/NCBI
7	Fridlyand LE and Philipson LH: Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann NY Acad Sci. 1066:136–151. 2005. View Article : Google Scholar : PubMed/NCBI
8	Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405–412. 1991. View Article : Google Scholar : PubMed/NCBI
9	Scully C, Epstein J and Sonis S: Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck. 25:1057–1070. 2003. View Article : Google Scholar : PubMed/NCBI
10	Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J and Calais G: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 22:69–76. 2004. View Article : Google Scholar
11	Fisher J, Scott C, Scarantino CW, Leveque FG, White RL, Rotman M, Hodson DI, Meredith RF, Foote R, Bachman DG and Lee N: Phase III quality-of-life study results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09. Int J Radiat Oncol Biol Phys. 56:832–836. 2003.
12	Chencharick JD and Mossman KL: Nutritional consequences of the radiotherapy of head and neck cancer. Cancer. 51:811–815. 1983. View Article : Google Scholar : PubMed/NCBI
13	Calviello G, Serini S, Piccioni E and Pessina G: Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer. 61:287–301. 2009. View Article : Google Scholar : PubMed/NCBI
14	Ruxton CH, Reed SC, Simpson MJ and Millington KJ: The health benefits of n-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet. 20:275–285. 2007. View Article : Google Scholar : PubMed/NCBI
15	Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC and Tisdale MJ: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 52:1479–1486. 2003. View Article : Google Scholar : PubMed/NCBI
16	Moses AW, Slater C, Preston T, Barber MD and Fearon KC: Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 90:996–1002. 2004. View Article : Google Scholar
17	Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G and Baracos V: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 21:129–134. 2003. View Article : Google Scholar : PubMed/NCBI
18	Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G and van Bokhorst-de van der Schueren MA; DGEM (German Society for Nutritional Medicine). Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ and Zander A; ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 25:245–259. 2006. View Article : Google Scholar : PubMed/NCBI
19	Jones D: ICRU Report 50 - Prescribing, recording and reporting photon beam therapy. Med Phys. 21:8331999. View Article : Google Scholar
20	Cox JD, Stetz J and Pajak TF: Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
21	Ali EM and Abdelraheem AG: Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck Oncol. 3:482011. View Article : Google Scholar : PubMed/NCBI
22	Somani N, Goyal S, Pasricha R, Khuteta N, Agarwal P, Garg AK and Singhal H: Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience. Indian J Med Paediatr Oncol. 32:86–91. 2011. View Article : Google Scholar
23	Kubrak C, Olson K, Jha N, Scrimger R, Parliament M, McCargar L, Koski S and Baracos VE: Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view. Head Neck. 35:695–703. 2013. View Article : Google Scholar : PubMed/NCBI
24	Chen CC, Chen WC, Lu CH, Wang WH, Lin PY, Lee KD and Chen MF: Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys. 76:1214–1224. 2010. View Article : Google Scholar : PubMed/NCBI
25	Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J and Jabbari MV: Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J. 28:435–440. 2007.PubMed/NCBI
26	Reddy VS, Dakshinamurty KV, Sherke RL and Neela Prasadd T: N-3 Polyunsaturated fatty acids in the prevention of progression of chronic renal disease. Indian J Nephrol. 12:6–9. 2002.
27	Sarsilmaz M, Songur A, Ozyurt H, Kuş I, Ozen OA, Ozyurt B, Söğüt S and Akyol O: Potential role of dietary ω-3 essential fatty acids on some oxidant/antioxidant parameters in rats’ corpus striatum. Prostaglandins Leukot Essent Fatty Acids. 69:253–259. 2003.
28	Hauenschild A, Bretzel RG, Schnell-Kretschmer H, Kloer HU, Hardt PD and Ewald N: Successful treatment of severe hypertriglyceridemia with a formula diet rich in n-3 fatty acids and medium-chain triglycerides. Ann Nutr Metab. 56:170–175. 2010. View Article : Google Scholar : PubMed/NCBI
29	Dhankhar R, Dahiya K, Sharma TK, Ghalaut VS, Atri R and Kaushal V: Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma. Clin Lab. 57:795–798. 2011.PubMed/NCBI
30	Bechoua S, Dubois M, Dominguez Z, Goncalves A, Némoz G, Lagarde M and Prigent AF: Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol. 57:1021–1030. 1999. View Article : Google Scholar : PubMed/NCBI
31	Machon C, Thezenas S, Dupuy AM, Assenat E, Michel F, Mas E, Senesse P and Cristol JP: Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer. 20:3129–3135. 2012. View Article : Google Scholar : PubMed/NCBI
32	Chen HH, Chen IH, Liao CT, Wei FC, Lee LY and Huang SF: Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol. 36:147–153. 2011. View Article : Google Scholar : PubMed/NCBI
33	Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Wu R, Fan YC, Zhong WZ, Wang SL, Zhang XY, Wu LN, Chen XD, Jin XY, Duan QY, Xu R, Chen W, Qian HC and Xiao YP: C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Tumour Biol. 33:891–895. 2012. View Article : Google Scholar : PubMed/NCBI
34	Peter F, Wittekindt C, Finkensieper M, Kiehntopf M and Guntinas-Lichius O: Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. J Cancer Res Clin Oncol. 139:171–178. 2013. View Article : Google Scholar : PubMed/NCBI
35	Helzlsouer KJ, Erlinger TP and Platz EA: C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer. 42:704–707. 2006. View Article : Google Scholar : PubMed/NCBI
36	Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ and Ghaderi A: Serum interleukin-6 concentration, but not interleukin-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res. 17:7–10. 2011. View Article : Google Scholar : PubMed/NCBI
37	Yadav A, Kumar B, Datta J, Teknos TN and Kumar P: IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
38	Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A and Balija M: Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal. 17:e10–e15. 2012. View Article : Google Scholar : PubMed/NCBI
39	De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R and Nuyts S: The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy chemotherapy. BMC Cancer. 5:422005.PubMed/NCBI
40	Nibali L, Fedele S, D’Aiuto F and Donos N: Interleukin-6 in oral diseases: a review. Oral Dis. 18:236–243. 2012. View Article : Google Scholar : PubMed/NCBI
41	Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM and Wright J: Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck. 34:985–993. 2012. View Article : Google Scholar : PubMed/NCBI
42	Salzman R, Pácal L, Kaňková K, Tomandl J, Horáková Z, Tóthová E and Kostřica R: High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma. Int J Clin Oncol. 15:565–570. 2010. View Article : Google Scholar : PubMed/NCBI
43	Ziech D, Franco R, Pappa A and Panayiotidis MI: Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 711:167–173. 2011. View Article : Google Scholar : PubMed/NCBI
44	Sharma PK, Dwarakanath BS and Varshney R: Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells. Free Radic Biol Med. 53:1500–1513. 2012. View Article : Google Scholar : PubMed/NCBI
45	Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D and Mitchell JB: Ionizing radiation-induced oxidative stress alters miRNA expression. PloS One. 4:e63772009. View Article : Google Scholar : PubMed/NCBI
46	Park KS, Lim JW and Kim H: Inhibitory mechanism of n-3 fatty acids in pancreatic inflammation and apoptosis. Ann NY Acad Sci. 1171:421–427. 2009. View Article : Google Scholar : PubMed/NCBI
47	Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS and Ger LP: Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck. 33:1606–1615. 2011. View Article : Google Scholar : PubMed/NCBI
48	Liu Z, Li S, Cai Y, Wang A, He Q, Zheng C, Zhao T, Ding X and Zhou X: Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H₂O₂-dependent Snail signaling. Free Radic Biol Med. 53:44–50. 2012. View Article : Google Scholar : PubMed/NCBI
49	Chen B, Rao X, House MG, Nephew KP, Cullen KJ and Guo Z: GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett. 309:37–45. 2011. View Article : Google Scholar : PubMed/NCBI
50	Korde SD, Basak A, Chaudhary M, Goyal M and Vagga A: Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology. 80:382–389. 2011. View Article : Google Scholar : PubMed/NCBI
51	Dahiya K, Dhankhar R, Madaan H, Singh V and Arora K: Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Ann Clin Lab Sci. 42:94–97. 2012.PubMed/NCBI
52	Mazière C, Conte MA, Degonville J, Ali D and Mazière JC: Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun. 265:116–122. 1999.PubMed/NCBI
53	Hafer K, Iwamoto KS and Schiestl RH: Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations. Radiat Res. 169:460–468. 2008. View Article : Google Scholar : PubMed/NCBI